WO2013019099A1 - Nanostructured carbonated hydroxy apatite and method and system for making the same - Google Patents

Nanostructured carbonated hydroxy apatite and method and system for making the same Download PDF

Info

Publication number
WO2013019099A1
WO2013019099A1 PCT/MY2011/000203 MY2011000203W WO2013019099A1 WO 2013019099 A1 WO2013019099 A1 WO 2013019099A1 MY 2011000203 W MY2011000203 W MY 2011000203W WO 2013019099 A1 WO2013019099 A1 WO 2013019099A1
Authority
WO
WIPO (PCT)
Prior art keywords
cha
nanostructured
predetermined temperature
sintering
sintered
Prior art date
Application number
PCT/MY2011/000203
Other languages
French (fr)
Inventor
Fauzi Mohd Noor Ahmad
Marliana Baba Ismail YANNY
Original Assignee
Universiti Sains Malaysia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universiti Sains Malaysia filed Critical Universiti Sains Malaysia
Publication of WO2013019099A1 publication Critical patent/WO2013019099A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02Inorganic materials
    • A61L27/12Phosphorus-containing materials, e.g. apatite
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01BNON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B25/00Phosphorus; Compounds thereof
    • C01B25/16Oxyacids of phosphorus; Salts thereof
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B35/00Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
    • C04B35/01Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products based on oxide ceramics
    • C04B35/447Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products based on oxide ceramics based on phosphates, e.g. hydroxyapatite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00Materials characterised by their function or physical properties
    • A61L2400/12Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/02Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/02Composition of constituents of the starting material or of secondary phases of the final product
    • C04B2235/30Constituents and secondary phases not being of a fibrous nature
    • C04B2235/32Metal oxides, mixed metal oxides, or oxide-forming salts thereof, e.g. carbonates, nitrates, (oxy)hydroxides, chlorides
    • C04B2235/3205Alkaline earth oxides or oxide forming salts thereof, e.g. beryllium oxide
    • C04B2235/3206Magnesium oxides or oxide-forming salts thereof
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/02Composition of constituents of the starting material or of secondary phases of the final product
    • C04B2235/30Constituents and secondary phases not being of a fibrous nature
    • C04B2235/32Metal oxides, mixed metal oxides, or oxide-forming salts thereof, e.g. carbonates, nitrates, (oxy)hydroxides, chlorides
    • C04B2235/3205Alkaline earth oxides or oxide forming salts thereof, e.g. beryllium oxide
    • C04B2235/3208Calcium oxide or oxide-forming salts thereof, e.g. lime
    • C04B2235/3212Calcium phosphates, e.g. hydroxyapatite
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/02Composition of constituents of the starting material or of secondary phases of the final product
    • C04B2235/30Constituents and secondary phases not being of a fibrous nature
    • C04B2235/44Metal salt constituents or additives chosen for the nature of the anions, e.g. hydrides or acetylacetonate
    • C04B2235/442Carbonates
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/65Aspects relating to heat treatments of ceramic bodies such as green ceramics or pre-sintered ceramics, e.g. burning, sintering or melting processes
    • C04B2235/656Aspects relating to heat treatments of ceramic bodies such as green ceramics or pre-sintered ceramics, e.g. burning, sintering or melting processes characterised by specific heating conditions during heat treatment
    • C04B2235/6562Heating rate
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/65Aspects relating to heat treatments of ceramic bodies such as green ceramics or pre-sintered ceramics, e.g. burning, sintering or melting processes
    • C04B2235/656Aspects relating to heat treatments of ceramic bodies such as green ceramics or pre-sintered ceramics, e.g. burning, sintering or melting processes characterised by specific heating conditions during heat treatment
    • C04B2235/6565Cooling rate
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/65Aspects relating to heat treatments of ceramic bodies such as green ceramics or pre-sintered ceramics, e.g. burning, sintering or melting processes
    • C04B2235/656Aspects relating to heat treatments of ceramic bodies such as green ceramics or pre-sintered ceramics, e.g. burning, sintering or melting processes characterised by specific heating conditions during heat treatment
    • C04B2235/6567Treatment time
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/65Aspects relating to heat treatments of ceramic bodies such as green ceramics or pre-sintered ceramics, e.g. burning, sintering or melting processes
    • C04B2235/658Atmosphere during thermal treatment
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/65Aspects relating to heat treatments of ceramic bodies such as green ceramics or pre-sintered ceramics, e.g. burning, sintering or melting processes
    • C04B2235/66Specific sintering techniques, e.g. centrifugal sintering
    • C04B2235/661Multi-step sintering
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/70Aspects relating to sintered or melt-casted ceramic products
    • C04B2235/74Physical characteristics
    • C04B2235/77Density
    • CCHEMISTRY; METALLURGY
    • C04CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
    • C04BLIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
    • C04B2235/00Aspects relating to ceramic starting mixtures or sintered ceramic products
    • C04B2235/70Aspects relating to sintered or melt-casted ceramic products
    • C04B2235/96Properties of ceramic products, e.g. mechanical properties such as strength, toughness, wear resistance

Definitions

  • the present invention relates generally to carbonate hydroxyapatite (CHA), and more particularly to a nanostructured CHA and method and system for making the same.
  • CHA hydroxyapatite
  • Bone graft can be defined as implanted or transplanted bone from another part of a human body or mammal, or as any synthetic material to reconstruct bone defects. Bone graft should provide a good local and systematic compatibility, and the capability of being a substitute for bones and completely filling any defect.
  • the sources of bone graft include another part of non-load bearing site of an individual's body (autograft), another human donor tissue (allograft), animal's tissue (xenograft), or synthetic biomaterials (artificial bones).
  • autograft, allograft and xenograft are known to have serious drawbacks to patients. Among others, the drawbacks include the possibility of the patients being infected by diseases, inadequate supplies and severe pain to the graft donor.
  • Hydroxyapatite (CalO(PO)4(OH)2) is one of the most widely used bioceramic in bone graft substitute, bone tissue engineering and drug delivery system. This is possible due to its biocompatibility, bioactivity, osteoconductivity and non-toxicity properties. It is also greatly influenced by its similarity in chemical structure with the biological apatite that comprises of the mineral phase of calcified tissue in the enamel, dentin and bone.
  • stoichiometric synthetic HA has been reported to have limited ability to form an interface and its resorption in vivo is too sluggish to induce a massive formation of a new bone tissue.
  • stoichiometric synthetic HA does not degrade significantly but rather remains as a permanent fixture susceptible to long term failure.
  • CHA carbonated hydroxyapatite
  • the biological apatite is referred as CHA.
  • the amount of carbonate in biological bones is about 2-8 wt% of the calcified tissue and may vary depending on the age factor.
  • Carbonate ion can substitute either in the hydroxyl groups (A-type) or the phosphate groups (B-type) or it can simultaneously substitute both hydroxyl and phosphate groups (AB-type).
  • CHA is a prospective material for biological applications in order to mimic the composition of natural bones.
  • CHA mechanical properties of CHA are known to be less than that of the cortical bone even though CHA has excellent bioactivity, biocompatibility and osteoconductivity and has already attracted much attention in the field of tissue engineering as bioresorbable bone graft substitutes as well as for dental replacement and repair.
  • Load bearing implant applications are hindered by the low strength and toughness of CHA, especially in wet environment, whereas applications of bulk CHA for nonstructural implants such as ossicles in ear have no particular difficulties.
  • One aspect of the present invention provides a method for preparing sintered nanostructured carbonated hydroxyapatite (CHA).
  • the method comprises mixing of CHA powders with a sintering aid to form a mixture, dry pressing the mixture, sintering the mixture at a first predetermined temperature for a first predetermined time period in air atmosphere without provision of external CO 2 gas to form nanostructured CHA, cooling the sintered nanostructured CHA to a second predetermined temperature, wherein the second predetermined temperature is lower than the first predetermined temperature, and refurbishing the sintered nanostructured CHA with wet C0 2 gas for a second predetermined time period.
  • Another aspect of the present invention provides a sintered nanostructured carbonated hydroxyapatite (CHA).
  • CHA sintered nanostructured carbonated hydroxyapatite
  • the system comprises a sintering module for sintering a CHA structure formed by pre-pressed CHA powders mixed with a sintering aid at a first predetermined temperature for a first predetermined period without supplying external C0 2 gas, and a carbonate refurbish module for refurbishing the sintered CHA at a second predetermined temperature for a second predetermined period, wherein the second predetermined temperature is lower than the first predetermined period, and the second predetermined period is longer than the first predetermined period; wherein the carbonate refurbish module comprises a wet C0 2 gas source, a high pressure tube with two ends, and a desiccator, where one end of the high pressure tube is conducively coupled with the wet C0 2 gas source and the other end of the high pressure tube with the desiccator, so that the wet C0 2 gas is channeled from the wet C0 2 gas source to the
  • FIG 1 shows a functional block diagram of the carbonate refurbish module in accordance with one embodiment of the present invention.
  • FIG 2 shows a flowchart of the method for preparing sintered nanostructured CHA in accordance with one embodiment of the present invention. Detailed Description of the Invention
  • Carbonated hydroxyapatite is meant to refer to any structure made from CHA powders or granules, where the structure can be bones, dental fixtures or the like, and its configurations and dimensions are dependent upon specific applications.
  • CHA powders or granules can be produced by any wet-chemical methods including precipitation in aqueous solution and nano-emulsion.
  • the wet-chemical process of sintering CHA is conducted in one step, sintering CHA at high temperature for a long period of time in the presence of C0 2 gas; the high temperature will cause carbonate decomposition, and the presence of C0 2 gas is intended to compensate the decomposed carbonate in the sintered CHA.
  • the wet-chemical process has many problems including high production cost and damages to the furnace.
  • the inventors of the present invention discovered that the addition of a sintering aid into CHA powders before sintering could lower the sintering temperature and shorten the sintering time period without compromising the mechanical properties of the sintered CHA and at the same time decrease the carbonate decomposition, making it possible that the sintering process is conducted without supplying external C0 2 gas.
  • the inventors of the present invention also discovered that the carbonate loss of the sintered CHA could be refurbished at a temperature much lower than the sintering temperature.
  • This two-step (sintering and refurbishing) process has many advantages over the wet-chemical ones. For example, no C0 2 gas supplied during sintering eliminates the furnace damages caused by C0 2 gas; the shortened sintering process at a lower temperature reduces the production cost.
  • the present invention provides a system for enabling the production of sintered nanostructured CHA in a two-step process.
  • the system comprises a sintering module and a carbonate refurbish module, where the sintering module can be separate from or integrated with the carbonate refurbish module, depending upon the actual design.
  • the sintering module sinters a CHA structure formed by pre-pressed CHA powders at a first predetermined temperature for a first predetermined period without supplying external C0 2 gas.
  • the first predetermined temperature is from 700-900°C
  • the first predetermined period is about 1-3 hours, more preferably 2 hours.
  • the sintering module can be any suitable furnace such as a Lenton tube furnace.
  • FIG 1 shows a functional block diagram of the carbonate refurbish module in accordance with one embodiment of the present invention.
  • the carbonate refurbish module 1 comprises a wet C0 2 gas source 10, a high pressure tube 20 with two ends, and a desiccator 30, where one end of the high pressure tube 20 is conducively coupled with the wet C0 2 gas source 10 and the other end of the high pressure tube 20 with the desiccator 30, so that the wet C0 2 gas is channeled from the wet C0 2 gas source to the desiccator 30.
  • the means for controlling the flow of C0 2 gas is not shown, and it can be any suitable means such as valves.
  • the desiccator 30 is preferably in a cylindrical configuration with integral ball- shaped top and bottom covers, forming a closed chamber. Within the chamber, a support 33 is provided for supporting a metal (e.g., alumina) crucible 31 on which the sintered CHA such as pellets is disposed. The bottom of the desiccator is filled with water 32 providing constant moisture to the closed chamber.
  • the desiccator 30 is kept constant at ambient temperature throughout the process (before, during and after flowing of wet C0 2 ) so that the sintered samples could be cooled down gradually with time.
  • the flow of wet C0 2 on the warm sintered samples helps the refurbishing process as the wet C0 2 is favorable to be adsorbed by the warm CHA due to strong affinity of C0 2 to Ca-based bioceramic compound.
  • the water in the desiccator 30 is just to ensure that the atmosphere inside the desiccator 30 is kept moist throughout the entire process.
  • the present invention also provides a method for producing sintered nanostructured CHA in a two-step manner.
  • the first step is sintering without supplying external C0 2 gas
  • the second step is refurbishing the sintered CHA with carbonate at a lowered temperature.
  • the method 100 commences by providing CHA powders that are mixed with a sintering aid 110, where the addition of the sintering aid reduces the sintering temperature and thus minimizing the decomposition of CHA.
  • a sintering aid 110 In the development of bioceramic, it is important to ensure that the sintering aids are non- toxic or causing no side-effects.
  • the sintering aid is magnesium hydroxide (Mg(OH) 2 ).
  • Mg(OH) 2 will then decompose to MgO that eventually forms Mg 2+ , while the residue H 2 0 being removed as gaseous form.
  • Mg 2+ element also occurs naturally in the mineral phase of the human bones and plays a role in overall bioactivity.
  • Mg(OH) 2 is usually used in the range of 5-10wt%. For making the samples analyzed in Table 1 below, Mg(OH) 2 was used in 8wt%.
  • the pressed mixture is then sintered in air atmosphere in a furnace 130.
  • the sintering is carried out at a first predetermined temperature from 700- 900°C for a first predetermined time period from 1 to 3 hours.
  • Mg(OH) 2 as the sintering aid, MgO during sintering reacts with CHA and forms a small amount of liquid phase between the particles or grains at the sintering temperature; this process is known as liquid-phase sintering.
  • the heating rate, soaking time and cooling rate for all the sintered materials were 10 /minute, 2 hours, and 10 /minutes, respectively.
  • the sintered CHA is then refurbished with external carbonate 140.
  • the sintered CHA after sintering is cooling down to a temperature between 200-400 °C, it was taken out from the furnace and placed in a desiccator. Immediately, wet carbon dioxide (C0 2 ) gas was flowed into the desiccator for about 20 minutes with the flowing rate of 0.5L/min. The sintered CHA was then kept in the desiccator for 24 hours, where the disiccator was kept at atmospheric pressure.
  • C0 2 wet carbon dioxide

Abstract

The present invention provides a method for preparing sintered nanostructured carbonated hydroxyapatite (CHA). The method comprises mixing of CHA powders with a sintering aid to form a mixture, dry pressing the mixture, sintering the mixture at a first predetermined temperature for a first predetermined time period in air atmosphere without provision of external C02 gas to form nanostructured CHA, cooling the nanostructured CHA to a second predetermined temperature, wherein the second predetermined temperature is lower than the first predetermined temperature, and refurbishing the nanostructured CHA with wet C02 gas for a second predetermined time period. The present invention also provides a sintered nanostructured carbonated hydroxyapatite (CHA). The present invention further provides a system for producing sintered nanostructured carbonated hydroxyapatite (CHA).

Description

NANOSTRUCTURED CARBONATED HYDROXY APATITE AND METHOD
AND SYSTEM FOR MAKING THE SAME
Field of the Invention
[0001] The present invention relates generally to carbonate hydroxyapatite (CHA), and more particularly to a nanostructured CHA and method and system for making the same. Background of the Invention
[0002] Bones are dynamic and highly vascularized tissues that continuously remodel themselves throughout the lifetime of an individual. Bones ensure that the skeleton has sufficient load-bearing capacity, and protect the delicate internal organs of a body. However, bones are prone to injury, defect and aging, resulting from many different causes. For example, trauma, infection, tumor or abnormal metabolism can cause bone injury; thus bone injury is a major public health problem. Dental and orthopaedics treatments also require adequate bone supplies and therefore the interest in bone regeneration is increasing. As a result, bone grafting or bone substitute has become critical in orthopaedics surgery.
[0003] Bone graft can be defined as implanted or transplanted bone from another part of a human body or mammal, or as any synthetic material to reconstruct bone defects. Bone graft should provide a good local and systematic compatibility, and the capability of being a substitute for bones and completely filling any defect. The sources of bone graft include another part of non-load bearing site of an individual's body (autograft), another human donor tissue (allograft), animal's tissue (xenograft), or synthetic biomaterials (artificial bones). However, autograft, allograft and xenograft are known to have serious drawbacks to patients. Among others, the drawbacks include the possibility of the patients being infected by diseases, inadequate supplies and severe pain to the graft donor.
[0004] Hydroxyapatite (HA) (CalO(PO)4(OH)2) is one of the most widely used bioceramic in bone graft substitute, bone tissue engineering and drug delivery system. This is possible due to its biocompatibility, bioactivity, osteoconductivity and non-toxicity properties. It is also greatly influenced by its similarity in chemical structure with the biological apatite that comprises of the mineral phase of calcified tissue in the enamel, dentin and bone. However, stoichiometric synthetic HA has been reported to have limited ability to form an interface and its resorption in vivo is too sluggish to induce a massive formation of a new bone tissue. In addition, stoichiometric synthetic HA does not degrade significantly but rather remains as a permanent fixture susceptible to long term failure.
[0005] One way to enhance the biological properties of HA implant is through chemical modification of HA. Recently, carbonated hydroxyapatite (CHA) has been reported to be superior to pure HA for being used as bioresorbable implants. This is because human and animal bone minerals have been shown to contain significant amounts of carbonate. Therefore, the biological apatite is referred as CHA. Generally, the amount of carbonate in biological bones is about 2-8 wt% of the calcified tissue and may vary depending on the age factor. Carbonate ion can substitute either in the hydroxyl groups (A-type) or the phosphate groups (B-type) or it can simultaneously substitute both hydroxyl and phosphate groups (AB-type). The presence of carbonate in the apatite lattice is known to increase the chemical reactivity of CHA and would therefore contribute to the ease of resorption in bony tissue. The incorporation of carbonate into HA would cause an increase in solubility, decrease in crystallinity, change in crystal morphology and better biological activity. With this, it is currently accepted that CHA is a prospective material for biological applications in order to mimic the composition of natural bones.
[0006] The mechanical properties of CHA are known to be less than that of the cortical bone even though CHA has excellent bioactivity, biocompatibility and osteoconductivity and has already attracted much attention in the field of tissue engineering as bioresorbable bone graft substitutes as well as for dental replacement and repair. Load bearing implant applications are hindered by the low strength and toughness of CHA, especially in wet environment, whereas applications of bulk CHA for nonstructural implants such as ossicles in ear have no particular difficulties.
[0007] Basically, the strength of carbonated hydroxyapatite (CHA) was found to be strongly dependent on the internal porosity of the compact and this can be controlled with proper sintering. Increasing the density by sintering will decrease the amount of porosity. However, the limited thermal stability of the CHA is a grave challenge to researchers. [0008] The presence of carbonate ions in apatite structure iafluence the decomposition and sinterability of CHA. Poor control of heat treatment of CHA would result in carbonate loss, leading to partial or total decomposition of the material and hence would affect the physical and mechanical properties of the synthetic material.
[0009] The attempts in the prior art to improve the mechanical properties of CHA included sintering of CHA in moist C02 atmosphere; it was claimed that sintering of CHA in moist C02 atmosphere could minimize the carbonate loss from the structure and at the same time promote densification. However, by flowing C02 gas, regardless it is dry or wet C02, throughout the sintering schedule which normally takes up 12-14 hours, could damage the furnace and increase the production cost. In addition, solid state sintering normally required high temperature, causing carbonate decomposition. The combination of high temperature and the use of C0 throughout the entire process in the furnace would cause the furnace to become brittle and prone to crack/break over longtime usage.
[0010] Therefore, the current process of making CHA needs to be improved.
Summary of the Invention
[0011] One aspect of the present invention provides a method for preparing sintered nanostructured carbonated hydroxyapatite (CHA). In one embodiment, the method comprises mixing of CHA powders with a sintering aid to form a mixture, dry pressing the mixture, sintering the mixture at a first predetermined temperature for a first predetermined time period in air atmosphere without provision of external CO2 gas to form nanostructured CHA, cooling the sintered nanostructured CHA to a second predetermined temperature, wherein the second predetermined temperature is lower than the first predetermined temperature, and refurbishing the sintered nanostructured CHA with wet C02 gas for a second predetermined time period.
[0012] Another aspect of the present invention provides a sintered nanostructured carbonated hydroxyapatite (CHA).
[0013] Yet another aspect of the present invention provides a system for producing sintered nanostructured carbonated hydroxyapatite (CHA). In one embodiment, the system comprises a sintering module for sintering a CHA structure formed by pre-pressed CHA powders mixed with a sintering aid at a first predetermined temperature for a first predetermined period without supplying external C02 gas, and a carbonate refurbish module for refurbishing the sintered CHA at a second predetermined temperature for a second predetermined period, wherein the second predetermined temperature is lower than the first predetermined period, and the second predetermined period is longer than the first predetermined period; wherein the carbonate refurbish module comprises a wet C02 gas source, a high pressure tube with two ends, and a desiccator, where one end of the high pressure tube is conducively coupled with the wet C02 gas source and the other end of the high pressure tube with the desiccator, so that the wet C02 gas is channeled from the wet C02 gas source to the desiccator; and wherein the desiccator has a chamber in which the sintered CHA is refurbished with external carbonate.
[0014] The objectives and advantages of the invention will become apparent from the following detailed description of preferred embodiments thereof in connection with the accompanying drawings. Brief Description of the Drawings
[0015] Preferred embodiments according to the present invention will now be described with reference to the Figures, in which like reference numerals denote like elements.
[0016] FIG 1 shows a functional block diagram of the carbonate refurbish module in accordance with one embodiment of the present invention.
[0017] FIG 2 shows a flowchart of the method for preparing sintered nanostructured CHA in accordance with one embodiment of the present invention. Detailed Description of the Invention
[0018] The present invention may be understood more readily by reference to the following detailed description of certain embodiments of the invention.
[0019] Throughout this application, where publications are referenced, the disclosures of these publications are hereby incorporated by reference, in their entireties, into this application in order to more fully describe the state of art to which this invention pertains. [0020] Carbonated hydroxyapatite (CHA) is meant to refer to any structure made from CHA powders or granules, where the structure can be bones, dental fixtures or the like, and its configurations and dimensions are dependent upon specific applications. CHA powders or granules can be produced by any wet-chemical methods including precipitation in aqueous solution and nano-emulsion.
[0021] As discussed above, the wet-chemical process of sintering CHA is conducted in one step, sintering CHA at high temperature for a long period of time in the presence of C02 gas; the high temperature will cause carbonate decomposition, and the presence of C02 gas is intended to compensate the decomposed carbonate in the sintered CHA. However, the wet-chemical process has many problems including high production cost and damages to the furnace. The inventors of the present invention discovered that the addition of a sintering aid into CHA powders before sintering could lower the sintering temperature and shorten the sintering time period without compromising the mechanical properties of the sintered CHA and at the same time decrease the carbonate decomposition, making it possible that the sintering process is conducted without supplying external C02 gas. The inventors of the present invention also discovered that the carbonate loss of the sintered CHA could be refurbished at a temperature much lower than the sintering temperature. This two-step (sintering and refurbishing) process has many advantages over the wet-chemical ones. For example, no C02 gas supplied during sintering eliminates the furnace damages caused by C02 gas; the shortened sintering process at a lower temperature reduces the production cost.
[0022] The present invention provides a system for enabling the production of sintered nanostructured CHA in a two-step process. The system comprises a sintering module and a carbonate refurbish module, where the sintering module can be separate from or integrated with the carbonate refurbish module, depending upon the actual design. The sintering module sinters a CHA structure formed by pre-pressed CHA powders at a first predetermined temperature for a first predetermined period without supplying external C02 gas. In some embodiments, the first predetermined temperature is from 700-900°C, and the first predetermined period is about 1-3 hours, more preferably 2 hours. The sintering module can be any suitable furnace such as a Lenton tube furnace.
[0023] The carbonate refurbish module refurbishes the sintered CHA at a second predetermined temperature for a second predetermined period, where the second predetermined temperature is lower than the first predetermined period, and the second predetermined period is longer than the first predetermined period. FIG 1 shows a functional block diagram of the carbonate refurbish module in accordance with one embodiment of the present invention. The carbonate refurbish module 1 comprises a wet C02 gas source 10, a high pressure tube 20 with two ends, and a desiccator 30, where one end of the high pressure tube 20 is conducively coupled with the wet C02 gas source 10 and the other end of the high pressure tube 20 with the desiccator 30, so that the wet C02 gas is channeled from the wet C02 gas source to the desiccator 30. The means for controlling the flow of C02 gas is not shown, and it can be any suitable means such as valves. The desiccator 30 is preferably in a cylindrical configuration with integral ball- shaped top and bottom covers, forming a closed chamber. Within the chamber, a support 33 is provided for supporting a metal (e.g., alumina) crucible 31 on which the sintered CHA such as pellets is disposed. The bottom of the desiccator is filled with water 32 providing constant moisture to the closed chamber. The desiccator 30 is kept constant at ambient temperature throughout the process (before, during and after flowing of wet C02) so that the sintered samples could be cooled down gradually with time. The flow of wet C02 on the warm sintered samples helps the refurbishing process as the wet C02 is favorable to be adsorbed by the warm CHA due to strong affinity of C02 to Ca-based bioceramic compound. The water in the desiccator 30 is just to ensure that the atmosphere inside the desiccator 30 is kept moist throughout the entire process.
[0024] The present invention also provides a method for producing sintered nanostructured CHA in a two-step manner. In brief, the first step is sintering without supplying external C02 gas, and the second step is refurbishing the sintered CHA with carbonate at a lowered temperature.
[0025] Referring now to FIG 2, there is provided a flowchart of the method for preparing sintered nanostructured CHA in accordance with one embodiment of the present invention. The method 100 commences by providing CHA powders that are mixed with a sintering aid 110, where the addition of the sintering aid reduces the sintering temperature and thus minimizing the decomposition of CHA. In the development of bioceramic, it is important to ensure that the sintering aids are non- toxic or causing no side-effects. In one embodiment, the sintering aid is magnesium hydroxide (Mg(OH) 2). During sintering, Mg(OH) 2 will then decompose to MgO that eventually forms Mg2+, while the residue H20 being removed as gaseous form. Mg2+ element also occurs naturally in the mineral phase of the human bones and plays a role in overall bioactivity. The introduction of Mg(OH) 2 as sintering aid improve the sintering; thus higher densification and good mechanical properties were achieved at much lower sintering temperature while minimizing decomposition of CHA. Mg(OH) 2 is usually used in the range of 5-10wt%. For making the samples analyzed in Table 1 below, Mg(OH) 2 was used in 8wt%.
[0026] The mixture is then pressed into the desired configuration and dimensions
120.
[0027] The pressed mixture is then sintered in air atmosphere in a furnace 130. In one embodiment, the sintering is carried out at a first predetermined temperature from 700- 900°C for a first predetermined time period from 1 to 3 hours. With the Mg(OH) 2 as the sintering aid, MgO during sintering reacts with CHA and forms a small amount of liquid phase between the particles or grains at the sintering temperature; this process is known as liquid-phase sintering. In one embodiment, the heating rate, soaking time and cooling rate for all the sintered materials were 10 /minute, 2 hours, and 10 /minutes, respectively.
[0028] The sintered CHA is then refurbished with external carbonate 140. In one embodiment, when the sintered CHA after sintering is cooling down to a temperature between 200-400 °C, it was taken out from the furnace and placed in a desiccator. Immediately, wet carbon dioxide (C02) gas was flowed into the desiccator for about 20 minutes with the flowing rate of 0.5L/min. The sintered CHA was then kept in the desiccator for 24 hours, where the disiccator was kept at atmospheric pressure.
[0029] From the results shown in Table 1, it is proved that this new method produced better synthetic CHA in terms of physical, mechanical and biological properties. It is also safer and economical for large scale production of synthetic CHA.
[0030] Table 1. Comparison of certain properties of CHA between prior arts and the present invention Properties Other Researchers In this study
Carbonate A-†ype CHA B-†ype CHA substitution [Teraoka et al., (1998)] (more (T= 900°C) desirable)
CO2 gas usage From beginning- end During cooling
[Zyman & Tkachenko (2010)] stage
Amount of 7.8 (T= 700 °C) 6.85 (T= 700 carbonate retained (pump CO2 for entire process) °C)
(w†%) [Barralet et al., (2000)]
Vickers hardness 1.17 (T= 800 °C) 2.37 (T= 800 (GPa) [Murulithran & Ramesh (2000)] °C)
Relative density (%) 94% (T= 1000 °C) 94% (T= 800
°C) 14 (T= 800 °C)
Compressive strength 22.95 (T= 800 (MPa.m ½) [Tkachenko & Zyman (2008)] °C)
[0031] While the present invention has been described with reference to particular embodiments, it will be understood that the embodiments are illustrative and that the invention scope is not so limited. Alternative embodiments of the present invention will become apparent to those having ordinary skill in the art to which the present invention pertains. Such alternate embodiments are considered to be encompassed within the scope of the present invention. Accordingly, the scope of the present invention is defined by the appended claims and is supported by the foregoing description.
[0032] References
[0033] Teraoka, K., Ito, A., Maekawa, K., Onuma, K., Tateishi, T., Tsutsumi, S.
(1998), Mechanical properties of hydroxyapatite and OH- carbonated hydroxyapatite single crystals, Journal of Dental Research 77: 1560-1568.
[0034] Zyman, Z. And Tkachenko, M. (2010), C02 gas-activated sintering of carbonated hydroxyapatites, Journal of European Ceramic Society 31: 241-248. [0035] Barralet, J.E., Best, S.M., Bonfield, W. (2000), Effect of sintering parameters on the density and microstructure of carbonated hydroxyapatite, Journal of Materials Science: Materials In Medicine 11 : 719-724.
[0036] Munilithran, G. and Ramesh, S. (2000), The effect of sintering temperature on the properties of hydroxyapatite, Ceramics International 25: 221-230.
[0037] Tkachenko, M.V., and Zyman, Z.Z. (2008), Effect of sintering conditions on physical properties of carbonated hydroxyapatite ceramics, Functional Materials 15: 574-578.

Claims

What is claimed is: 1. A method for preparing sintered nanostructured carbonated hydroxyapatite (CHA), said method comprising:
mixing of CHA powders with a sintering aid to form a mixture;
dry pressing the mixture;
sintering the mixture at a first predetermined temperature for a first predetermined time period in air atmosphere without provision of external C02 gas to form nanostructured CHA;
cooling the sintered nanostructured CHA to a second predetermined temperature, wherein the second predetermined temperature is lower than the first predetermined temperature; and
refurbishing the nanostructured CHA with wet C02 gas for a second predetermined time period.
2. The method of claim 1, wherein the sintering aid is magnesium hydroxide (Mg(OH)2).
3. The method of claim 1, wherein the first predetermined temperature is 700-900°C, and the first predetermined time period is 1 to 3 hours.
4. The method of claim 1, wherein the second predetermined temperature is 200- 400°C.
5. The method of claim 1, wherein the second predetermined time period is 24 hours.
6. A sintered nanostructured carbonated hydroxyapatite (CHA) made by the method of claim 1.
7. The sintered nanostructured CHA of claim 6, wherein the sintering aid is magnesium hydroxide (Mg(OH) 2).
8. The sintered nanostructured CHA of claim 6, wherein the first predetermined temperature is 700-900°C, and the first predetermined time period is 1 to 3 hours.
9. The sintered nanostructured CHA of claim 6, wherein the second predetermined temperature is 200-400T.
10. The sintered nanostructured CHA of claim 6, wherein the second predetermined time period is 24 hours.
11. A system for producing sintered nanostructured carbonated hydroxyapatite (CHA), comprising:
a sintering module for sintering a CHA structure formed by pre-pressed CHA powders mixed with a sintering aid at a first predetermined temperature for a first predetermined period without supplying external C02 gas; and
a carbonate refurbish module for refurbishing the sintered CHA at a second predetermined temperature for a second predetermined period, wherein the second predetermined temperature is lower than the first predetermined period, and the second predetermined period is longer than the first predetermined period;
wherein the carbonate refurbish module comprises a wet C02 gas source, a high pressure tube with two ends, and a desiccator, where one end of the high pressure tube is conducively coupled with the wet C02 gas source and the other end of the high pressure tube with the desiccator, so that the wet C02 gas is channeled from the wet C02 gas source to the desiccator; and
wherein the desiccator has a chamber in which the sintered CHA is refurbished with external carbonate.
The system of claim 11, wherein the sintering module is a Lenton tube furnace.
13. The system of claim 1 1, wherein the sintering aid is magnesium hydroxide ( g(OH) 2).
14. The system of claim 1 1 , wherein the first predetermined temperature is 700-900 , and the first predetermined time period is 1 to 3 hours.
15. The system of claim 11, wherein the second predetermined temperature is 200- 400°C.
16. The system of claim 1 1, wherein the second predetermined time period is 24 hours.
PCT/MY2011/000203 2011-08-03 2011-09-13 Nanostructured carbonated hydroxy apatite and method and system for making the same WO2013019099A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MYPI2011003611 2011-08-03
MYPI2011003611 2011-08-03

Publications (1)

Publication Number Publication Date
WO2013019099A1 true WO2013019099A1 (en) 2013-02-07

Family

ID=47629495

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/MY2011/000203 WO2013019099A1 (en) 2011-08-03 2011-09-13 Nanostructured carbonated hydroxy apatite and method and system for making the same

Country Status (1)

Country Link
WO (1) WO2013019099A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015191426A1 (en) * 2014-06-10 2015-12-17 Porvair Plc Magnesium oxide filter made from burned magnesium oxide

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0625490B1 (en) * 1993-05-19 1996-06-19 Queen Mary And Westfield College Method for the preparation of carbonated hydroxyapatite compositions
USRE41584E1 (en) * 1997-01-16 2010-08-24 Massachusetts Institute Of Technology Nanocrystalline apatites and composites, prostheses incorporating them, and method for their production
CN101934096A (en) * 2009-06-25 2011-01-05 四川大学 Ca-P biological glass-ceramic compound nano biological ceramic and preparation method thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0625490B1 (en) * 1993-05-19 1996-06-19 Queen Mary And Westfield College Method for the preparation of carbonated hydroxyapatite compositions
USRE41584E1 (en) * 1997-01-16 2010-08-24 Massachusetts Institute Of Technology Nanocrystalline apatites and composites, prostheses incorporating them, and method for their production
CN101934096A (en) * 2009-06-25 2011-01-05 四川大学 Ca-P biological glass-ceramic compound nano biological ceramic and preparation method thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015191426A1 (en) * 2014-06-10 2015-12-17 Porvair Plc Magnesium oxide filter made from burned magnesium oxide

Similar Documents

Publication Publication Date Title
Dorozhkin Medical application of calcium orthophosphate bioceramics
Ghosh et al. In vivo response of porous hydroxyapatite and β‐tricalcium phosphate prepared by aqueous solution combustion method and comparison with bioglass scaffolds
Jones et al. Biomedical materials for new millennium: perspective on the future
EP2396046B1 (en) Bone regeneration materials based on combinations of monetite and other bioactive calcium and silicon compounds
Wang et al. Biological evaluation of biphasic calcium phosphate ceramic vertebral laminae
Shanmugam et al. Bioceramics-an introductory overview
EP2403544B1 (en) Galliated calcium phosphate biomaterials
Shigeishi et al. Clinical evaluation of novel interconnected porous hydroxyapatite ceramics (IP-CHA) in a maxillary sinus floor augmentation procedure
Bayazit et al. Evaluation of bioceramic materials in biology and medicine
US8399009B2 (en) Bioceramic and biopolymer composite
WO2005102281A2 (en) Porous calcium phosphate networks for synthetic bone material
Hsu et al. A head-to-head comparison of the degradation rate of resorbable bioceramics
Dorozhkin Calcium orthophosphate bioceramics
Kang et al. Synthesis and characterization of β-tricalcium phosphate derived from Haliotis sp. shells
US20020136696A1 (en) Orthopedic and dental ceramic implants
Ana Bone substituting materials in dental implantology
Jones et al. Ceramics, glasses, and glass-ceramics: Basic principles
Regi et al. Degradative effects of the biological environment on ceramic biomaterials
Zhu et al. Cemented injectable multi-phased porous bone grafts for the treatment of femoral head necrosis
JPWO2008066106A1 (en) Biological laminated gradient material and method for producing the same
WO2013019099A1 (en) Nanostructured carbonated hydroxy apatite and method and system for making the same
Wang Hydroxyapatite degradation and biocompatibility
US20140305344A1 (en) Magnesium phosphate biomaterials
Komlev et al. Effect of the concentration of carbonate groups in a carbonate hydroxyapatite ceramic on its in vivo behavior
da Silva et al. Alveolar regeneration induced by calcium phosphate ceramics after dental avulsion: Study in young rats

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11870483

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11870483

Country of ref document: EP

Kind code of ref document: A1